NASDAQ : LFWD
Lifeward Ltd. — Key statistics
Healthcare · Medical Devices · Israel
Last price 5.91 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 16.74M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 16.86M |
| Enterprise Value | 14.40M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 2.83M |
| Shares Outstanding | 2.83M |
| Shares Change (YoY) | +121.56% |
| Shares Change (QoQ) | +73.60% |
| Owned by Insiders (%) | 0.49% |
| Owned by Institutions (%) | 1.44% |
| Float | 1.57M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.77 |
| Forward PS | 0.48 |
| PB Ratio | 1.38 |
| P/TBV Ratio | 2.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.33 |
| Quick Ratio | 1.55 |
| Debt / Equity | 0.57 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -74.86 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -225.65% |
| Return on Assets (ROA) | -47.26% |
| Return on Invested Capital (ROIC) | -84.17% |
| Return on Capital Employed (ROCE) | -97.97% |
| Weighted Average Cost of Capital (WACC) | 5.89% |
| Revenue Per Employee | $269,407 |
| Profits Per Employee | -$380,617 |
| Employee Count | 81 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 2.03 |
Taxes
| Measure | Value |
|---|
| Income Tax | -50,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.48 |
| 52-Week Price Change | -24.74% |
| 50-Day Moving Average | 6.66 |
| 200-Day Moving Average | 6.96 |
| Relative Strength Index (RSI) | 44.90 |
| Average Volume (20 Days) | 11,926 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 89,640 |
| Short Previous Month | 96,512 |
| Short % of Shares Out | 3.17% |
| Short % of Float | 5.72% |
| Short Ratio (days to cover) | 17.34 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 21.82M |
| Gross Profit | 7.85M |
| Operating Income | -23.36M |
| Pretax Income | -30.88M |
| Net Income | -30.83M |
| EBITDA | -22.98M |
| EBIT | -23.36M |
| Loss Per Share | -$17.00 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 9.45M |
| Total Debt | 6.99M |
| Net Cash | 2.46M |
| Net Cash Per Share | $0.87 |
| Equity (Book Value) | 12.22M |
| Book Value Per Share | 4.32 |
| Working Capital | 14.79M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -17.08M |
| Capital Expenditures | -19,000 |
| Depreciation & Amortization | 375,000 |
| Net Borrowing | 8.50M |
| Free Cash Flow | -17.10M |
| FCF Per Share | -$6.04 |
Margins
| Measure | Value |
|---|
| Gross Margin | 35.95% |
| Operating Margin | -107.03% |
| Pretax Margin | -141.51% |
| Profit Margin | -141.28% |
| EBITDA Margin | -105.32% |
| EBIT Margin | -107.03% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -121.56% |
| Shareholder Yield | -121.56% |
| Earnings Yield | -285.68% |
| FCF Yield | -101.43% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $20.00 |
| Price Target Difference | 236.04% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 36.55% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Feb 24, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -13.03 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |